Literature DB >> 22961163

Tracking the insidious course of Alzheimer's disease.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22961163     DOI: 10.1038/nm.2922

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift.

Authors:  Todd E Golde; Lon S Schneider; Edward H Koo
Journal:  Neuron       Date:  2011-01-27       Impact factor: 17.173

2.  Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation.

Authors:  F Lopera; A Ardilla; A Martínez; L Madrigal; J C Arango-Viana; C A Lemere; J C Arango-Lasprilla; L Hincapíe; M Arcos-Burgos; J E Ossa; I M Behrens; J Norton; C Lendon; A M Goate; A Ruiz-Linares; M Rosselli; K S Kosik
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

3.  Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study.

Authors:  Natalia Acosta-Baena; Diego Sepulveda-Falla; Carlos Mario Lopera-Gómez; Mario César Jaramillo-Elorza; Sonia Moreno; Daniel Camilo Aguirre-Acevedo; Amanda Saldarriaga; Francisco Lopera
Journal:  Lancet Neurol       Date:  2011-02-04       Impact factor: 44.182

4.  ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.

Authors:  Paige E Cramer; John R Cirrito; Daniel W Wesson; C Y Daniel Lee; J Colleen Karlo; Adriana E Zinn; Brad T Casali; Jessica L Restivo; Whitney D Goebel; Michael J James; Kurt R Brunden; Donald A Wilson; Gary E Landreth
Journal:  Science       Date:  2012-02-09       Impact factor: 47.728

5.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

6.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Authors:  Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

  6 in total
  1 in total

Review 1.  Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease.

Authors:  Xi-Lin Wu; Juan Piña-Crespo; Yun-Wu Zhang; Xiao-Chun Chen; Hua-Xi Xu
Journal:  Chin Med J (Engl)       Date:  2017-12-20       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.